A carregar...

Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial.

Allogeneic hematopoietic cell transplantation (HCT) may improve long-term multiple myeloma (MM) control through graft vs myeloma (GVM) effect. The BMT CTN 0102 was a biological assignment trial comparing tandem autologous transplant (auto-auto) vs. autologous followed by reduced intensity allogeneic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Giralt, Sergio, Costa, Luciano J., Maloney, David, Krishnan, Amrita, Fei, Mingwei, Antin, Joseph H., Brunstein, Claudio, Geller, Nancy, Goodman, Stacey, Hari, Parameswaran, Logan, Brent, Lowsky, Robert, Qazilbash, Muzaffar H., Sahebi, Firoozeh, Somlo, George, Rowley, Scott, Vogl, Dan T., Vesole, David H, Pasquini, Marcelo, Stadtmauer, Edward
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7198329/
https://ncbi.nlm.nih.gov/pubmed/31756536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.11.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!